tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KLRS Stock Latest News

Three new option listings and ten option delistings on July 21st
The FlyThree new option listings and ten option delistings on July 21st
2d ago
YI
HES
Kalaris Therapeutics Adjusts Annual Meeting Schedule
PremiumCompany Announcements
Kalaris Therapeutics Adjusts Annual Meeting Schedule
1M ago
8K
KLRS
Positive Outlook on Kalaris Therapeutics: Promising Phase 1 Trial and Strong Financial Position Justify Buy Rating
PremiumRatings
Positive Outlook on Kalaris Therapeutics: Promising Phase 1 Trial and Strong Financial Position Justify Buy Rating
2M ago
KLRS
Kalaris Therapeutics Reports Q1 2025 Financials and Progress
PremiumCompany Announcements
Kalaris Therapeutics Reports Q1 2025 Financials and Progress
2M ago
KLRS
Buy Rating for Kalaris Therapeutics: Promising TH103 Development and Strong Financial Position
PremiumRatings
Buy Rating for Kalaris Therapeutics: Promising TH103 Development and Strong Financial Position
2M ago
KLRS
Kalaris Therapeutics reports Q1 EPS ($2.52) vs ($2.60) last year
PremiumThe FlyKalaris Therapeutics reports Q1 EPS ($2.52) vs ($2.60) last year
2M ago
KLRS
Buy Rating for Kalaris Therapeutics Driven by Promising Market Potential and Innovative TH103 Therapy
Premium
Ratings
Buy Rating for Kalaris Therapeutics Driven by Promising Market Potential and Innovative TH103 Therapy
3M ago
KLRS
Kalaris Therapeutics Amends Executive Employment Agreements
Premium
Company Announcements
Kalaris Therapeutics Amends Executive Employment Agreements
3M ago
8K
KLRS
Kalaris Therapeutic Inc. trading resumes
PremiumThe Fly
Kalaris Therapeutic Inc. trading resumes
3M ago
KLRS
Kalaris Therapeutic Inc. trading halted, volatility trading pause
PremiumThe Fly
Kalaris Therapeutic Inc. trading halted, volatility trading pause
3M ago
KLRS
Kalaris Therapeutics initiated with an Outperform at William Blair
PremiumThe Fly
Kalaris Therapeutics initiated with an Outperform at William Blair
4M ago
KLRS
Kalaris Therapeutics initiated with an Outperform at William Blair
PremiumThe Fly
Kalaris Therapeutics initiated with an Outperform at William Blair
4M ago
KLRS
Buy Rating for Kalaris Therapeutics: Promising Advancements in Retinal Vascular Disease Market
PremiumRatingsBuy Rating for Kalaris Therapeutics: Promising Advancements in Retinal Vascular Disease Market
4M ago
KLRS
Kalaris Therapeutics Appoints Leone Patterson to Board
Premium
Company Announcements
Kalaris Therapeutics Appoints Leone Patterson to Board
4M ago
8K
KLRS
Kalaris Therapeutics appoints Leone Patterson to board of directors
Premium
The Fly
Kalaris Therapeutics appoints Leone Patterson to board of directors
4M ago
KLRS
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >